Cellular Biology |
From the Franz Volhard Clinic and Max Delbrück Center for Molecular Medicine, Charité University Hospitals, Humboldt University of Berlin, Germany, and Medical School Hannover, Department of Nephrology, Hannover, Germany.
Correspondence to Maik Gollasch, MD, PhD, Franz Volhard Clinic, Wiltbergstrasse 50, 13125 Berlin, Germany. E-mail gollasch{at}fvk-berlin.de
| Abstract |
|---|
|
|
|---|
Key Words: caveolae arterial tone excitation-contraction coupling ryanodine receptor L-type calcium channel
| Introduction |
|---|
|
|
|---|
In arterial SMCs, Ca2+ sparks indirectly cause vasodilatation through activation of plasmalemmal KCa channels but have little direct effect on spatially averaged [Ca2+]i that regulates contraction.3 14 15 In cardiac ventricular and skeletal muscle cells, Ca2+ sparks originate at transverse tubules.8 9 How cells provide efficient Ca2+ entry to induce Ca2+ sparks in cells lacking the transverse tubular membrane system is unknown. Arterial SMCs, mammalian atrial cells, and neonatal cardiomyocytes lack the transverse tubular membrane system (References 16 and 1716 17 and unpublished data, April 2000) but have been shown to generate spatially localized, subsarcolemmal, transient Ca2+ release events (Ca2+ sparks).3 14 17 In these cells, infoldings of the surface membrane (caveolae) are abundant.18 Caveolae contain DHP-sensitive Ca2+ channels19 and may colocalize with junctional SR.20 Thus, caveolae may play an important role in providing the structural relationship between caveolemmal Ca2+ channels and RyR Ca2+ release channels located in the adjacent junctional SR. Caveolae would thereby be essential to generate local Ca2+ release events (Ca2+ sparks).
We monitored elementary ryanodine-sensitive Ca2+ release events (Ca2+ sparks) by measuring rapid local changes in [Ca2+]i in SMCs isolated from resistance-sized cerebral arteries and cardiomyocytes obtained from neonatal hearts, respectively. We provide evidence that the transient elevation in [Ca2+]i triggering SR Ca2+ release is established locally in the caveolae microdomain between the caveolemmal Ca2+ channel and multiple RyR Ca2+ release channels located in the adjacent junctional SR.
| Materials and Methods |
|---|
|
|
|---|
An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.
| Results |
|---|
|
|
|---|
|
|
To test whether the analysis of
Ca2+ spark properties on different amplitude
levels introduced changes and, therefore, different results
(Figures 1B
, 1C
, 1E
, and 1F
; red lines within the Figures
indicate the level used for the analysis of
Ca2+ spark amplitude), 2 modes of analysis
were compared. Ca2+ spark widths were
analyzed either at FWHM50
(Figures 1B
and 1E
) or at the beginning of the
Ca2+ spark amplitude
(FWHM100
[Figures 1C
and 1F
]).
The analysis revealed a consistent reduction of Ca2+ spark
width at FWHM50 and
FWHM100. To obtain the exact start of the
Ca2+ spark amplitude is often complicated
because of fluorescence noise. Therefore,
Ca2+ spark width was measured continuously
at FWHM50.
In neonatal cardiomyocytes
(Figure 2
), frequency, peak
[Ca2+]i amplitude
of Ca2+ sparks (measured as
F/Fo), width, and duration of
Ca2+ sparks at FWHM50
were 0.071±0.008
events · µm-1 · s-1
(n=60 cells), 1.7±0.06 µm (n=47 sparks), 3.55±0.44 µm (n=19
sparks), and 43±3.8 ms (n=24 sparks), respectively. Ryanodine, which
inhibits SR Ca2+ release channels at
micromolar concentrations, blocked Ca2+
sparks in both arterial SMCs and adult cardiac muscle
cells.3 14 15 25
The Ca2+ spark frequency in both arterial
SMCs and neonatal cardiomyocytes was increased by the DHP agonist
BayK8644 (1 µmol/L, n=14 cardiomyocytes) (see Figure 1
online,
available at http://www.circresaha.org) by membrane depolarization
(using 60 mmol/L external K+) or by the RyR
activator caffeine (300 µmol/L) (see also References 3 and
253 25 ). In contrast, the frequency of
Ca2+ sparks was inhibited by the DHP
antagonist nimodipine (100 nmol/L, n=21 neonatal cardiomyocytes) or by
ryanodine (10 µmol/L, n=22 neonatal cardiomyocytes, n=22 arterial
SMCs) (see Figure 1
online). Thus, there was no difference between
elementary Ca2+ signaling in both arterial
SMCs and neonatal heart muscle. These results support previous findings
showing that most Ca2+ sparks in both cell
types result from the openings of ryanodine-sensitive
Ca2+ release channels in SR in close
proximity to the cell-surface
membrane3 15 25
and that Ca2+ entry through a single
DHP-sensitive Ca2+ channel is the activator
of a Ca2+
spark.6 7 11
The proximity of the Ca2+
sparks to the cell surface raises the possibility that caveolae serve
as microdomains to provide efficient, local, and stable
Ca2+ signal transmission in releasing SR
Ca2+ sparks (elementary
Ca2+ induced Ca2+
release). Caveolae are 20- to 50-nm invaginations of the plasma
membrane that are abundant in arterial
SMCs20 and neonatal
cardiomyocytes26 and
colocalize with the subsarcolemmal occurrence of
Ca2+ sparks in those cells (this study).
Caveolae are rich in cholesterol and sphingolipids; the
cholesterol-to-protein ratio of the caveolae fraction is 4 to 5 times
higher than in the surrounding plasma
membrane.27 Experimentally
lowering the cholesterol level of the caveolar fraction disrupts the
molecular assembly and ultrastructure of the caveolae
domain.27 28 We
acutely lowered the cholesterol level of the caveolae fraction by
incubating arterial SMCs and neonatal cardiomyocytes in the presence of
1 mmol/L methyl-ß-cyclodextrin (dextrin) for 1 hour at 37°C. After
incubation, we studied the ultrastructure and measured
Ca2+ sparks in single cells in PSS.
Figure 3
shows that caveolae are abundant in neonatal
cardiomyocytes (upper panel). Incubation of neonatal cardiomyocytes
with dextrin resulted in a dose-dependent destruction of caveolae.
Similar results were obtained in arterial SMCs, as reported by
others18 28 (see
Figure 2
online, available at http://www.circresaha.org).
|
Dextrin treatment had major effects on
Ca2+ sparks in arterial myocytes. As shown
in
Figure 2
, the frequency of Ca2+
sparks in SMCs was significantly decreased from 0.025±0.003
events · µm-1 · s-1
(n=956 cells) to 0.017± 0.004
events · µm-1 · s-1
(n=214 cells; P<0.05). The
peak [Ca2+]i
Ca2+ spark amplitudes (measured as
F/Fo) decreased from 2.1±0.2 (n=81 sparks) to
1.64±0.06 (n=92 sparks;
P<0.05). The
Ca2+ sparks after incubating cells with
dextrin were smaller in spatial size. As shown in
Figure 1B
and 1E
, the full width at
FWHM50 of the sparks was reduced at all time
points of the spark life cycle (2.89±0.2 µm, n=44 sparks versus
2.29±0.2 µm, n=45 sparks for control versus dextrin-treated cells,
respectively; P<0.05) (see
Figure 2
). Similar results were observed when
Ca2+ spark width was analyzed at 100%
(Figures 1C
and 1F
) and 25% of peak
F/Fo amplitude, respectively (not shown).
However, the duration of Ca2+ sparks was not
different between control cells and dextrin-treated arterial SMCs
(45.2±2.6 ms, n=81 sparks versus 44.8±1.9 ms, n=93 sparks for control
versus dextrin-treated cells, respectively;
P>0.05) (see Figure 2
).
Similar results were observed in neonatal
cardiomyocytes.
Figure 2
shows that dextrin treatment of cardiomyocytes
decreased the frequency of Ca2+ sparks from
0.071±0.008
events · µm-1 · s-1
(n=60 cells) to 0.024±0.003
events · µm-1 · s-1
(n=98 cells; P<0.05), the peak
[Ca2+]i amplitude
of Ca2+ sparks (measured as
F/Fo) from 1.7±0.06 (n=47 sparks) to 1.4±0.03
(n=52 sparks; P<0.05), and the
spatial size (full width at FWHM50, 3.55±0.44
µm, n=19 sparks versus 1.6±0.3 µm, n=20 sparks for control versus
dextrin-treated cells, respectively;
P<0.05). The duration of
Ca2+ sparks in control cardiomyocytes
(43±3.8 ms, n=24 sparks) was not different from cardiomyocytes treated
with dextrin (41±3.9 ms, n=23 sparks;
P>0.05). Thus, we conclude
that cholesterol depletion by dextrin destroys caveolae and decreases
frequency, amplitude, and spatial size of
Ca2+ sparks in arterial SMCs and
cardiomyocytes lacking the transverse tubular membrane system. The
temporal characteristics of Ca2+ sparks are
not significantly affected. That pixel filtering is responsible for the
observed changes in Ca2+ spark properties by
dextrin is unlikely. As shown in Figure 3
online (available at
http://www.circresaha.org), Ca2+ spark
amplitudes processed with 1-, 3-, or 5-pixel filtering were reduced by
only 3%, 3.5%, and 3.7%, respectively. Because of these small
effects, 1-, 3-, and 5-pixel filtering increased
Ca2+ spark duration in nontreated and
dextrin-treated cells by <2%. The effects of dextrin on
Ca2+ sparks were dose- and time-dependent.
Figure 4
shows that dextrin at 1 µmol/L and 1 mmol/L
reduced the Ca2+ spark frequency in arterial
SMCs (P<0.03).
|
To examine the possible direct effects of dextrin on
voltage-dependent, DHP-sensitive (L-type)
Ca2+ channel currents, we measured
whole-cell Ca2+ channel currents in fresh
isolated single vascular SMCs and neonatal
cardiomyocytes.22 23
Membrane capacitance of both vascular SMCs (7.8±0.3 pF, n=12 versus
7.5±0.4 pF, n=14 for control versus dextrin-treated cells,
respectively; P>0.05) and
neonatal cardiomyocytes (3.44±0.31 pF, n=20 versus 2.73±0.37 pF,
n=15; P=0.05) were unchanged
after treatment with dextrin.
Figure 5A
shows that the whole-cell
Ca2+ channel current in SMCs was not
affected by dextrin pretreatment. Dextrin-treated cells exhibited
Ca2+ channel currents that were not
different in amplitude, activation, and inactivation kinetics than
control cells.
Figure 5B
shows the current-voltage relation of peak
Ca2+ channel currents without () and
after (
) incubation of cells with dextrin (1 mmol/L, 37°C).
Solid lines are drawn according to the following equation, assuming a
Boltzmann type of channel activation:
ICa=gmax(V-Vrev){1+exp[(V0.5-V)/h]}-1,
where
ICa (pA)
is the peak Ca2+ channel current,
V0.5
(mV) is the potential of half-maximal activation,
V (mV) is the test potential,
gmax
(pS) is the maximal conductance,
Vrev
(mV) is the extrapolated reversal potential, and
h is the slope factor of
Ca2+ channel activation. Statistical
analysis of the fits revealed that
gmax,
V0.5,
h, and
Vrev
were not significantly altered (gmax, 1.6±0.1
and 1.8±0.2 pS;
V0.5,
0.22±0.9 and 1.6±0.4 mV; h,
5.9±0.4 and 4.3±0.45 mV;
Vrev,
49±1.9 and 51±0.7 mV for control [n=11] and dextrin-treated
[n=13] cells, respectively;
P>0.05). Similar results were
obtained for L-type Ca2+ channel currents in
neonatal cardiomyocytes
(P>0.05)
(Figure 5C
).
|
To examine whether dextrin had an effect on
VM and thus might indirectly affect
voltage-dependent Ca2+ entry through
DHP-sensitive Ca2+ channels, we next
measured VM by the whole-cell perforated
patch-clamp technique in single
SMCs.22 Steady-state
VM was not different between control cells
(-18±4 mV, n=7) and dextrin-treated arterial SMCs (-18±3 mV, n=7,
P>0.05)
(Figure 6
). These results indicate that the changes of
Ca2+ spark properties in dextrin-treated
cells occurred without alteration of the properties of DHP-sensitive
Ca2+ channels or of cell
VM, indicating that the trigger for SR
Ca2+ release is unaltered after caveolae
depletion.
|
To explore possible changes in the function of RyRs or
the SR content, the effects of 10 mmol/L caffeine were examined. This
caffeine concentration was previously
shown14 to cause a typical
whole-cell global Ca2+ transient in adult
rat cerebral myocytes and neonatal rat cardiomyocytes because of the
rapid activation of RyRs. Such caffeine-induced
Ca2+ transients have been used routinely to
measure SR Ca2+ content in muscle
cells.14 15 Rapid
application of caffeine (10 mmol/L) to dextrin-treated arterial SMCs
caused a global Ca2+ transient with an
amplitude (F/Fo=5.4±0.5, n=20) similar to
nontreated cells (F/FO=5.3±0.5, n=17)
(Figures 7A
and 7B
). Similar results were obtained in neonatal
cardiomyocytes
(Figure 7C
). These results indicate that RyRs are functional
and that differences in SR Ca2+ load are not
responsible for the observed differences in
Ca2+ spark frequency and characteristics
after treatment of cells with dextrin.
|
| Discussion |
|---|
|
|
|---|
40 ms)
that is regulated by the intrinsic properties of activated RyRs. This
multi-RyR channel model explains how destruction of caveolae decreases
frequency, amplitude, and spatial size of
Ca2+ sparks in arterial SMCs and
cardiomyocytes without significantly changing the temporal
characteristics of a Ca2+ spark. According
to this model, destruction of caveolae enhances the distance (by up to
20 to 50 nm) between the caveolemmal Ca2+
channel and multiple RyR Ca2+ release
channels. Thus, the transient elevation in
[Ca2+]i at the
inner mouth of the caveolemmal Ca2+ channel
that triggers SR Ca2+ release activates a
smaller number of RyRs located in the adjacent junctional SR, producing
a smaller Ca2+ spark without changing their
duration. In sharp contrast, Ca2+ sparks
based on individual RyRs would have been expected to exhibit
spatial-temporal characteristics that are not affected by destruction
of caveolae. The multi-RyR hypothesis supports the idea that an
individual RyR may release a fundamental
Ca2+ release event, ie,
Ca2+
quark.29 Because
Ca2+ quarks are not detectable by presently
available confocal laser scanning
microscopy,14 29
we conclude that the Ca2+ sparks (elementary
Ca2+ release units) observed in
dextrin-treated cells represent Ca2+ release
events by simultaneous opening of at least 2 RyRs. Our interpretation
of caveolar Ca2+ signaling is strengthened
by the observation that Ca2+ sparks occur
repeatedly at defined discharge sites with relatively stable
spatial-temporal characteristics (usually at 2 to 3
Ca2+ spark sites per cell) despite the large
number of RyRs along the cell membrane in arterial
SMCs.14 Our interpretation
is consistent with recent findings suggesting that the simultaneous
opening of multiple RyRs is responsible for the generation of a
Ca2+ spark event despite large uncertainties
in the suggested number of RyRs involved. The number may range from <8
RyRs30 to 8
RyRs31 to >8
RyRs.32 Nevertheless, we
observed a modal amplitude distribution of
Ca2+ sparks in both arterial SMCs and
neonatal cardiomyocytes (data not shown), clearly indicating that
Ca2+ sparks represent
Ca2+ release events by simultaneous opening
of multiple RyRs but not of a single
RyR.32
|
In conclusion, our data indicate that in SMCs and cardiomyocytes caveolae appear to be membrane hot spots for local Ca2+ signaling. Caveolae have been implicated in signal transduction, vesicular trafficking, lipid metabolism, and cellular growth control in adipocytes, endothelia, neuronal cells, and fibroblasts.27 We propose that caveolae perform localized and very specific Ca2+ signaling functions in the absence of global cytosolic Ca2+ elevations. Our data suggest that Ca2+ sparks are of multi-RyR channel origin and that the spatial characteristics of Ca2+ sparks are controlled by caveolar microarchitecture, assembled by a mixture of lipids and proteins (eg, caveolins and cavatellins) unlike those found in the plasma membrane proper.27 Alterations in the caveolar microarchitecture may lead to pathophysiological changes in Ca2+ signaling. Thus, caveolae may be intimately involved in cardiovascular cell dysfunction and disease.
| Acknowledgments |
|---|
This work was supported by a Deutsche Forschungsgemeinschaft grant (M.G.) and by Boehringer Ingelheim Fonds (M.F. and M.L.). We are grateful to Dr T. Kurzchalia for advice in using methyl-ß-cyclodextrin. We thank Mrs Kott and Dr H. Haase for preparing neonatal cardiomyocytes.
Received August 4, 2000; revision received September 28, 2000; accepted September 28, 2000.
| References |
|---|
|
|
|---|
2.
Cheng H,
Lederer WJ, Cannell MB. Calcium sparks: elementary events underlying
excitation-contraction coupling in heart muscle.
Science. 1993;262:740744.
3.
Nelson MT,
Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer WJ.
Relaxation of arterial smooth muscle by calcium sparks.
Science. 1995;270:633637.
4.
Shirokova N,
Garcia J, Rios E. Local calcium release in mammalian skeletal muscle.
J Physiol (Lond). 1998;512:377384.
5. Sorrentino V, Volpe P. Ryanodine receptors: how many, where and why? Trends Pharmacol Sci. 1993;14:98103.[Medline] [Order article via Infotrieve]
6.
Lopez-Lopez
JR, Shacklock PS, Balke CW, Wier WG. Local calcium transients triggered
by single L-type calcium channel currents in cardiac cells.
Science. 1995;268:10421045.
7.
Shorofsky SR,
Izu L, Wier WG, Balke CW. Ca2+ sparks
triggered by patch depolarization in rat heart cells.
Circ Res. 1998;82:4249.
8.
Parker I,
Zang WJ, Wier WG. Ca2+ sparks involving
multiple Ca2+ release sites along Z-lines in
rat heart cells. J Physiol
(Lond). 1996;497:3138.
9.
Shacklock PS,
Wier WG, Balke CW. Local Ca2+ transients
(Ca2+ sparks) originate at transverse
tubules in rat heart cells. J Physiol
(Lond). 1995;487:601608.
10.
Stern
MD, Pizarro G, Rios E. Local control model of excitation-contraction
coupling in skeletal muscle. J Gen
Physiol. 1997;110:415440.
11.
Santana
LF, Cheng H, Gomez AM, Cannell MB, Lederer WJ. Relation between the
sarcolemmal Ca2+ current and
Ca2+ sparks and local control theories for
cardiac excitation-contraction coupling.
Circ Res. 1996;78:166171.
12.
Collier ML,
Thomas AP, Berlin JR. Relationship between L-type
Ca2+ current and unitary sarcoplasmic
reticulum Ca2+ release events in rat
ventricular myocytes. J Physiol
(Lond). 1999;516:117128.
13.
Cannell MB,
Cheng H, Lederer WJ. The control of calcium release in heart muscle.
Science. 1995;268:10451049.
14.
Gollasch M,
Wellman GC, Knot HJ, Jaggar JH, Damon DH, Bonev AD, Nelson MT. Ontogeny
of local sarcoplasmic reticulum Ca2+ signals
in cerebral arteries: Ca2+ sparks as
elementary physiological events. Circ
Res. 1998;83:11041114.
15. Jaggar JH, Wellman GC, Heppner TJ, Porter VA, Perez GJ, Knot HJ, Gollasch M, Kleppisch T, Rubart M, Stevenson AS, Lederer WJ, Bonev AD, Nelson MT. Ca2+ channels, ryanodine receptors and Ca2+-activated K+ channels: a functional unit for regulating arterial tone. Acta Scand Physiol. 1998;164:577588.[Medline] [Order article via Infotrieve]
16.
Frank JS,
Mottino G, Chen F, Peri V, Holland P, Tuana BS. Subcellular
distribution of dystrophin in isolated adult and neonatal cardiac
myocytes. Am J Physiol. 1994;267:C1707C1716.
17.
Hüser J,
Lipsius SL, Blatter LA. Calcium gradients during excitation-contraction
coupling in cat atrial myocytes. J
Physiol. 1996;494:641651.
18. Thyberg J, Tran PK, Blomgren K, Dumitrescu A, Hedin U. Expression of caveolae on the surface of rat arterial smooth muscle is dependent on the phenotypic state of the cells. Lab Invest. 1997;1997:1:93101.
19. Jorgenson AO, Shen AC, Arnold W, Leung AT, Campbell KP. Subcellular distribution of the 1,4-dihydropyridine receptor in rabbit skeletal muscle in situ: an immunofluorescence and immunocolloidal gold-labeled study. J Cell Biol. 1989;1:135147.
20.
Devine CE,
Somlyo AV, Somlyo AP. Sarcoplasmic reticulum and excitation-contraction
coupling in mammalian smooth muscles.
J Cell Biol. 1972;52:690718.
21. Luther HP, Morwinski R, Wallukat G, Haase H, Morano I. Expression of sense and naturally occurring antisense mRNA of myosin heavy chain in rat heart tissue and cultivated cardiomyocytes. J Mol Cell Cardiol. 1997;1:2735.
22.
Gollasch M,
Ried C, Bychkov R, Luft FC, Haller H. K+
currents in human coronary artery vascular smooth muscle cells.
Circ Res. 1996;78:676688.
23.
Gollasch M,
Kleuss C, Hescheler J, Wittig B, Schultz G. Gi2
and protein kinase C are required for thyrotropin-releasing
hormone-induced stimulation of voltage-dependent
Ca2+ channels in pituitary
GH3 cells. Proc
Natl Acad Sci
U S A.. 1993;90:62656269.
24.
Perez GJ,
Bonev AD, Patlak JB, Nelson MT. Functional coupling of ryanodine
receptors to KCa channels in smooth muscle cells
from rat cerebral arteries. J Gen
Physiol. 1999;113:229237.
25.
Jaggar JH,
Stevenson AS, Nelson MT. Voltage dependence of
Ca2+ sparks in intact cerebral arteries.
Am J Physiol. 1998;274:C1755C1761.
26.
Hammes A,
Oberdorf-Maas S, Rother T, Nething K, Gollnick F, Linz KW, Meyer R, Hu
K, Han H, Gaudron P, Ertl G, Hoffmann S, Ganten U, Vetter R, Schuh K,
Benkwitz C, Zimmer HG, Neyses L. Overexpression of the sarcolemmal
calcium pump in the myocardium of transgenic rats.
Circ Res. 1998;83:966998.
27. Anderson RGW. The caveolae membrane system. Annu Rev Biochem. 1998;67:199225.[Medline] [Order article via Infotrieve]
28. Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, Sandvig K. Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clatherin-coated endocytic vesicles. J Mol Biol Cell. 1999;10:961974.
29.
Lipp P,
Niggli E. Fundamental calcium release events revealed by two-photon
photolysis of caged calcium in guinea-pig cardiac myocytes.
J Physiol. 1998;508:801809.
30.
Gonzalez A,
Kirsch WG, Shirokova N, Pizarro G, Brum G, Pessah IN, Stern MD, Cheng
H, Rios E. Involvement of multiple intracellular release channels in
calcium sparks of skeletal muscle. Proc
Natl Acad Sci
U S A.. 2000;97:43805.
31. Rice JJ, Jafri MS, Winslow RL. Modeling gain and gradedness of Ca2+ release in the functional unit of the cardiac diadic space. Biophys J. 1999;77:187184.[Medline] [Order article via Infotrieve]
32. Bridge JH, Ershler PR, Cannell MB. Properties of Ca2+ sparks evoked by action potentials in mouse ventricular myocytes. J Physiol (Lond). 1999;518(pt 2):46978.
This article has been cited by other articles:
![]() |
E. N. Dedkova and L. A. Blatter Characteristics and function of cardiac mitochondrial nitric oxide synthase J. Physiol., February 15, 2009; 587(4): 851 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Younes, A. E. Lyashkov, D. Graham, A. Sheydina, M. V. Volkova, M. Mitsak, T. M. Vinogradova, Y. O. Lukyanenko, Y. Li, A. M. Ruknudin, et al. Ca2+-stimulated Basal Adenylyl Cyclase Activity Localization in Membrane Lipid Microdomains of Cardiac Sinoatrial Nodal Pacemaker Cells J. Biol. Chem., May 23, 2008; 283(21): 14461 - 14468. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Belmonte and M. Morad 'Pressure-flow'-triggered intracellular Ca2+ transients in rat cardiac myocytes: possible mechanisms and role of mitochondria J. Physiol., March 1, 2008; 586(5): 1379 - 1397. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Prakash, M. A. Thompson, B. Vaa, I. Matabdin, T. E. Peterson, T. He, and C. M. Pabelick Caveolins and intracellular calcium regulation in human airway smooth muscle Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1118 - L1126. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Essin, A. Welling, F. Hofmann, F. C. Luft, M. Gollasch, and S. Moosmang Indirect coupling between Cav1.2 channels and ryanodine receptors to generate Ca2+ sparks in murine arterial smooth muscle cells J. Physiol., October 1, 2007; 584(1): 205 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Somara, R. R. Gilmont, J. R. Martens, and K. N. Bitar Ectopic expression of caveolin-1 restores physiological contractile response of aged colonic smooth muscle Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G240 - G249. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kamishima, T. Burdyga, J. A. Gallagher, and J. M. Quayle Caveolin-1 and caveolin-3 regulate Ca2+ homeostasis of single smooth muscle cells from rat cerebral resistance arteries Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H204 - H214. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rueda, M. Song, L. Toro, E. Stefani, and H. H. Valdivia Sorcin modulation of Ca2+ sparks in rat vascular smooth muscle cells J. Physiol., November 1, 2006; 576(3): 887 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cheng and J. H. Jaggar Genetic ablation of caveolin-1 modifies Ca2+ spark coupling in murine arterial smooth muscle cells Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2309 - H2319. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Balijepalli, J. D. Foell, D. D. Hall, J. W. Hell, and T. J. Kamp From the Cover: Localization of cardiac L-type Ca2+ channels to a caveolar macromolecular signaling complex is required for beta2-adrenergic regulation PNAS, May 9, 2006; 103(19): 7500 - 7505. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Sheehan, A. V. Zima, and L. A. Blatter Regional differences in spontaneous Ca2+ spark activity and regulation in cat atrial myocytes J. Physiol., May 1, 2006; 572(3): 799 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fleming Segregation and integration: Roles played by caveolae and caveolins in the cardiovascular system Cardiovasc Res, March 1, 2006; 69(4): 784 - 787. [Full Text] [PDF] |
||||
![]() |
O. Feron and J.-L. Balligand Caveolins and the regulation of endothelial nitric oxide synthase in the heart Cardiovasc Res, March 1, 2006; 69(4): 788 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Hardin and J. Vallejo Caveolins in vascular smooth muscle: Form organizing function Cardiovasc Res, March 1, 2006; 69(4): 808 - 815. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Calaghan and E. White Caveolae modulate excitation-contraction coupling and {beta}2-adrenergic signalling in adult rat ventricular myocytes Cardiovasc Res, March 1, 2006; 69(4): 816 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shaw, M. A. Sweeney, S. C. O'Neill, C. J.P. Jones, C. Austin, and M. J. Taggart Caveolae and sarcoplasmic reticular coupling in smooth muscle cells of pressurised arteries: The relevance for Ca2+ oscillations and tone Cardiovasc Res, March 1, 2006; 69(4): 825 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vial and R. J. Evans Disruption of Lipid Rafts Inhibits P2X1 Receptor-mediated Currents and Arterial Vasoconstriction J. Biol. Chem., September 2, 2005; 280(35): 30705 - 30711. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Gutterman Mitochondria and Reactive Oxygen Species: An Evolution in Function Circ. Res., August 19, 2005; 97(4): 302 - 304. [Full Text] [PDF] |
||||
![]() |
Y. G Wang, E. N Dedkova, X Ji, L. A Blatter, and S. L Lipsius Phenylephrine acts via IP3-dependent intracellular NO release to stimulate L-type Ca2+ current in cat atrial myocytes J. Physiol., August 15, 2005; 567(1): 143 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ratajczak, P. Oliviero, F. Marotte, F. Kolar, B. Ostadal, and J.-L. Samuel Expression and localization of caveolins during postnatal development in rat heart: implication of thyroid hormone J Appl Physiol, July 1, 2005; 99(1): 244 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Brainard, A. J. Miller, J. R. Martens, and S. K. England Maxi-K channels localize to caveolae in human myometrium: a role for an actin-channel-caveolin complex in the regulation of myometrial smooth muscle K+ current Am J Physiol Cell Physiol, July 1, 2005; 289(1): C49 - C57. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-L. Wang, D. Ye, T. E. Peterson, S. Cao, V. H. Shah, Z. S. Katusic, G. C. Sieck, and H.-C. Lee Caveolae Targeting and Regulation of Large Conductance Ca2+-activated K+ Channels in Vascular Endothelial Cells J. Biol. Chem., March 25, 2005; 280(12): 11656 - 11664. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Daniel, G. Bodie, M. Mannarino, G. Boddy, and W.-J. Cho Changes in membrane cholesterol affect caveolin-1 localization and ICC-pacing in mouse jejunum Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G202 - G210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Gratton, P. Bernatchez, and W. C. Sessa Caveolae and Caveolins in the Cardiovascular System Circ. Res., June 11, 2004; 94(11): 1408 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Xia, X. Gao, E. Kwan, P. P. L. Lam, L. Chan, K. Sy, L. Sheu, M. B. Wheeler, H. Y. Gaisano, and R. G. Tsushima Disruption of Pancreatic {beta}-Cell Lipid Rafts Modifies Kv2.1 Channel Gating and Insulin Exocytosis J. Biol. Chem., June 4, 2004; 279(23): 24685 - 24691. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Bowles, C. L. Heaps, J. R. Turk, K. K. Maddali, and E. M. Price Hypercholesterolemia inhibits L-type calcium current in coronary macro-, not microcirculation J Appl Physiol, June 1, 2004; 96(6): 2240 - 2248. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pouvreau, C. Berthier, S. Blaineau, J. Amsellem, R. Coronado, and C. Strube Membrane cholesterol modulates dihydropyridine receptor function in mice fetal skeletal muscle cells J. Physiol., March 1, 2004; 555(2): 365 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Dedkova, X. Ji, S. L. Lipsius, and L. A. Blatter Mitochondrial calcium uptake stimulates nitric oxide production in mitochondria of bovine vascular endothelial cells Am J Physiol Cell Physiol, February 1, 2004; 286(2): C406 - C415. [Abstract] [Full Text] |
||||
![]() |
S. Kawamura, S. Miyamoto, and J. H. Brown Initiation and Transduction of Stretch-induced RhoA and Rac1 Activation through Caveolae: CYTOSKELETAL REGULATION OF ERK TRANSLOCATION J. Biol. Chem., August 15, 2003; 278(33): 31111 - 31117. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, K. Mohammadi, B. Aynafshar, H. Wang, D. Li, J. Liu, A. V. Ivanov, Z. Xie, and A. Askari Role of caveolae in signal-transducing function of cardiac Na+/K+-ATPase Am J Physiol Cell Physiol, June 1, 2003; 284(6): C1550 - C1560. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Seki, M. Nagashima, Y. Yamada, M. Tsutsuura, T. Kobayashi, A. Namiki, and N. Tohse Fetal and postnatal development of Ca2+ transients and Ca2+ sparks in rat cardiomyocytes Cardiovasc Res, June 1, 2003; 58(3): 535 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M Kirk, L. T Izu, Y. Chen-Izu, S. L McCulle, W G. Wier, C W. Balke, and S. R Shorofsky Role of the Transverse-Axial Tubule System in Generating Calcium Sparks and Calcium Transients in Rat Atrial Myocytes J. Physiol., March 1, 2003; 547(2): 441 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Isshiki, Y.-s. Ying, T. Fujita, and R. G. W. Anderson A Molecular Sensor Detects Signal Transduction from Caveolae in Living Cells J. Biol. Chem., November 1, 2002; 277(45): 43389 - 43398. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dreja, M. Voldstedlund, J. Vinten, J. Tranum-Jensen, P. Hellstrand, and K. Sward Cholesterol Depletion Disrupts Caveolae and Differentially Impairs Agonist-Induced Arterial Contraction Arterioscler Thromb Vasc Biol, August 1, 2002; 22(8): 1267 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
D V Gordienko and T B Bolton Crosstalk between ryanodine receptors and IP3 receptors as a factor shaping spontaneous Ca2+-release events in rabbit portal vein myocytes J. Physiol., August 1, 2002; 542(3): 743 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Feron and R. A. Kelly Gaining Respectability: Membrane-Delimited, Caveolar-Restricted Activation of Ion Channels Circ. Res., March 8, 2002; 90(4): 369 - 370. [Full Text] [PDF] |
||||
![]() |
R. S. Ostrom, C. Gregorian, R. M. Drenan, Y. Xiang, J. W. Regan, and P. A. Insel Receptor Number and Caveolar Co-localization Determine Receptor Coupling Efficiency to Adenylyl Cyclase J. Biol. Chem., November 2, 2001; 276(45): 42063 - 42069. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Mironneau, F Coussin, J L Morel, C Barbot, L H Jeyakumar, S Fleischer, and C Mironneau Calcium signalling through nucleotide receptor P2X1 in rat portal vein myocytes J. Physiol., October 15, 2001; 536(2): 339 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lohn, B. Lauterbach, H. Haller, O. Pongs, F. C. Luft, and M. Gollasch {beta}1-subunit of BK channels regulates arterial wall [Ca2+] and diameter in mouse cerebral arteries J Appl Physiol, September 1, 2001; 91(3): 1350 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Sanders Signal Transduction in Smooth Muscle: Invited Review: Mechanisms of calcium handling in smooth muscles J Appl Physiol, September 1, 2001; 91(3): 1438 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Hill, H. Zou, S. J. Potocnik, G. A. Meininger, and M. J. Davis Signal Transduction in Smooth Muscle: Invited Review: Arteriolar smooth muscle mechanotransduction: Ca2+ signaling pathways underlying myogenic reactivity J Appl Physiol, August 1, 2001; 91(2): 973 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Jaggar Intravascular pressure regulates local and global Ca2+ signaling in cerebral artery smooth muscle cells Am J Physiol Cell Physiol, August 1, 2001; 281(2): C439 - C448. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |